Expert Panel Recommendations for the Use of Anti–Tumor Necrosis Factor Biologic Agents in Patients with Ocular Inflammatory Disorders
Author:
Publisher
Elsevier BV
Subject
Ophthalmology
Reference176 articles.
1. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel;Jabs;Am J Ophthalmol,2000
2. Assessing the quality of research;Glasziou;BMJ,2004
3. GRADE guidelines: 3. Rating the quality of evidence;Balshem;J Clin Epidemiol,2011
4. Auditing the implementation of SIGN (Scottish Intercollegiate Guidelines Network) clinical guidelines;Keaney;Int J Health Care Qual Assur Inc Leadersh Health Serv,1999
5. Do tumor necrosis factor inhibitors cause uveitis? A registry-based study;Lim;Arthritis Rheum,2007
Cited by 404 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Treatment of Behçet Uveitis in Türkiye;Turkish Journal of Ophthalmology;2024-08-29
2. Intravenous Golimumab in the Treatment of Juvenile Idiopathic Arthritis and Its Associated Uveitis;Ocular Immunology and Inflammation;2024-08-29
3. Recent advances in the diagnosis and management of Behçet’s syndrome uveitis;Expert Review of Ophthalmology;2024-08-17
4. Treatment options for necrotizing scleritis in rheumatoid arthritis patients;Expert Review of Ophthalmology;2024-07-23
5. Predictive factors and adalimumab efficacy in managing chronic recurrence Vogt-Koyanagi-Harada disease;BMC Ophthalmology;2024-06-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3